Form 4 for QUBT Quantum Computing Inc.
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0001213900-25-054931 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-16 | 2025-06-13 | QUBT | Boehmler Christopher | CFO | M - OptEx | $1.82 | +351.2K | 351.2K | New | +$638.9K |
| D | 2025-06-16 | 2025-06-12 | QUBT | Boehmler Christopher | CFO | S - Sale+OE | $20.00 | -46.4K | 0 | -100% | -$928.8K |
| DM | 2025-06-16 | 2025-06-13 | QUBT | Boehmler Christopher | CFO | D - Sale to Iss | $0.00 | -403.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-13 | M | A | 185,719 | $1.18 | 270,328 | D | — | — | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. (F2) The total number of shares of Common Stock beneficially owned directly by the Reporting Person does not include 164,814 shares of Common Stock issuable upon exercise of vested options to purchase shares of common stock. |
| 2 | Common | Common Stock | 2025-06-13 | M | A | 7,495 | $2.37 | 84,609 | D | — | — | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. (F2) The total number of shares of Common Stock beneficially owned directly by the Reporting Person does not include 164,814 shares of Common Stock issuable upon exercise of vested options to purchase shares of common stock. |
| 3 | Common | Common Stock | 2025-06-13 | M | A | 58,510 | $0.46 | 328,838 | D | — | — | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. (F2) The total number of shares of Common Stock beneficially owned directly by the Reporting Person does not include 164,814 shares of Common Stock issuable upon exercise of vested options to purchase shares of common stock. |
| 4 | Common | Common Stock | 2025-06-13 | M | A | 77,114 | $2.56 | 77,114 | D | — | — | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. (F2) The total number of shares of Common Stock beneficially owned directly by the Reporting Person does not include 164,814 shares of Common Stock issuable upon exercise of vested options to purchase shares of common stock. |
| 5 | Common | Common Stock | 2025-06-13 | M | A | 22,314 | $7.96 | 351,152 | D | — | — | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. (F2) The total number of shares of Common Stock beneficially owned directly by the Reporting Person does not include 164,814 shares of Common Stock issuable upon exercise of vested options to purchase shares of common stock. |
| 6 | Common | Common Stock | 2025-06-12 | S | D | 46,440 | $20.00 | 0 | D | — | — | (F2) The total number of shares of Common Stock beneficially owned directly by the Reporting Person does not include 164,814 shares of Common Stock issuable upon exercise of vested options to purchase shares of common stock. |
| 7 | Derivative | Options to Purchase Shares of Common Stock | 2025-06-13 | D | D | 60,186 | $0.00 | 0 | D | $0.46 · — to 2029-10-04 | 58,510 Common Stock | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. |
| 8 | Derivative | Options to Purchase Shares of Common Stock | 2025-06-13 | D | D | 91,250 | $0.00 | 0 | D | $2.56 · — to 2027-03-28 | 77,114 Common Stock | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. |
| 9 | Derivative | Options to Purchase Shares of Common Stock | 2025-06-13 | D | D | 8,750 | $0.00 | 0 | D | $2.37 · — to 2027-10-12 | 7,495 Common Stock | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. |
| 10 | Derivative | Options to Purchase Shares of Common Stock | 2025-06-13 | D | D | 200,000 | $0.00 | 0 | D | $1.18 · — to 2028-12-27 | 185,719 Common Stock | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. |
| 11 | Derivative | Options to Purchase Shares of Common Stock | 2025-06-13 | D | D | 43,050 | $0.00 | 0 | D | $7.96 · — to 2030-02-19 | 22,314 Common Stock | (F1) These shares were acquired by the Reporting Person on June 13, 2025 by exercising 403,236 stock options to purchase shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), all of which were vested, using a "net exercise" method at a cashless exercise price of $16.526 per share, resulting in the issuance of 351,152 shares of Common Stock. |